In light of this and studies suggesting a direct involvement of TLR4-mediated inflammation in the development of HF diet-induced hepatic steatosis and insulin resistance, there is a concerted effort directed at developing therapeutics targeting TLR4 signaling. Here, TLR4 is linked to Insulin resistance.